+27 (0)83 440 0793 mark.fyvie@vxpharma.com
Select Page
NICE chief exec questions real costs of R&D

NICE chief exec questions real costs of R&D

In a letter to UK newspaper The Times, the chief executive of the National Institute for Health and Care Excellence (NICE) has challenged the real costs of pharmaceutical research and development. Sir Andrew Dillon, who has headed up the UK health technology...